A Medicine Adoption Model for Assessing the Expected Effects of Additional Real-World Evidence (RWE) at Product Launch

CONCLUSIONS: The proposed model provides an intuitive temporal framework within which subsystem logic can be further researched to identify and address stakeholder groups' needs and weigh those needs. Preliminary results appear to support adopting a multiple stakeholder approach to RWE for augmenting the uptake of novel medicines.PMID:34176383 | DOI:10.1080/03007995.2021.1947218

Source: Current Medical Research and Opinion - June 28, 2021 Category: Research Authors: Ravi Jandhyala Source Type: research